share_log

HC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $41 Price Target

HC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $41 Price Target

HC Wainwright & Co.重申買入Syndax Pharmicals,維持41美元的目標股價
Benzinga ·  05/09 06:56

HC Wainwright & Co. analyst Edward White reiterates Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and maintains $41 price target.

HC Wainwright & Co. 分析師愛德華·懷特重申Syndax Pharmicals(納斯達克股票代碼:SNDX)的買入並維持41美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論